Meilleure Health International Industry Group (HKG:2327) First Half 2024 Results
Key Financial Results
- Revenue: HK$30.0m (down 60% from 1H 2023).
- Net income: HK$8.47m (down 53% from 1H 2023).
- Profit margin: 28% (up from 24% in 1H 2023).
- EPS: HK$0.002 (down from HK$0.004 in 1H 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Meilleure Health International Industry Group's share price is broadly unchanged from a week ago.
Risk Analysis
You should learn about the 2 warning signs we've spotted with Meilleure Health International Industry Group.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.